Bridgebio Oncology Therapeutics, Inc. · NASDAQ:BBOT
Deerfield Management Company, L.P. reported a 6.17% stake in Bridgebio Oncology Therapeutics, Inc. (Schedule 13G)
Event Aug 11, 2025 · Filed Aug 18, 2025
Deerfield Management Company, L.P. reported a 6.17% stake in Bridgebio Oncology Therapeutics, Inc., 4,885,446 shares, as a passive investor on Aug 11, 2025. Filed Aug 18, 2025 (Schedule 13G).
- Stake
- 6.17%
- Shares
- 4,885,446
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deerfield Mgmt, L.P. | 3.08% | 2,442,723 |
| Deerfield Mgmt V, L.P. | 3.08% | 2,442,723 |
| Deerfield Partners, L.P. | 3.08% | 2,442,723 |
| Deerfield Private Design Fund V, L.P. | 3.08% | 2,442,723 |
| Deerfield Management Company, L.P. | 6.17% | 4,885,446 |
| James E. Flynn | 6.17% | 4,885,446 |